Arcutis Biotherapeutics, Inc. (ARQT) Tops Q1 EPS by 37c
Tweet
Share
E-mailGet Alerts ARQT Hot Sheet
Join SI Premium – FREE
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) reported Q1 EPS of ($0.32), $0.37 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $49.56 million versus the consensus estimate of $14.8 million.
For earnings history and earnings-related data on Arcutis Biotherapeutics, Inc. (ARQT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cintas beats estimates but stock edges lower
- Worthington Industries (WOR) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
